We are live on ! Find out more
SPC

Slate Path Capital Portfolio holdings

AUM $6.73B
1-Year Est. Return 95.97%
This Fund
S&P 500
This Quarter Est. Return
+6.81%
1 Year Est. Return
+95.97%
3 Year Est. Return
+272.8%
5 Year Est. Return
+330.15%
10 Year Est. Return
+4,591.92%
AUM
$2.63B
AUM Growth
+$589M
Cap. Flow
+$495M
Cap. Flow %
18.81%
Top 10 Hldgs %
88.03%
Holding
19
New
5
Increased
2
Reduced
9
Closed
3

Top Buys

Rank Stock Value
1
CAR icon
Avis
CAR
+$79.9M
2
DXC icon
DXC Technology
DXC
+$67.1M
3
P
Pandora Media Inc
P
+$53M
4
TWTR
Twitter, Inc.
TWTR
+$34.1M
5
ALLY icon
Ally Financial
ALLY
+$3.14M

Top Sells

Rank Stock Value
1
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$286M
2
X
US Steel
X
+$105M
3
DXCM icon
DexCom
DXCM
+$94.9M
4
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$55.3M
5
ANDV
Andeavor
ANDV
+$53.6M

Sector Composition

Rank Sector Weight
1 Communication Services 19.88%
2 Healthcare 8.88%
3 Financials 8.4%
4 Consumer Discretionary 4.63%
5 Energy 4.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
1
CALL
Invesco QQQ Trust
QQQ
$436B
$551M 20.91%
+4,000,000
New +$550M
SPY icon
2
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$423M 16.07%
+1,750,000
New +$419M
TWTR
3
DELISTED
Twitter, Inc.
TWTR
$271M 10.28%
15,140,000
+2,000,000
+15% +$34.1M
ALLY icon
4
Ally Financial
ALLY
$13.1B
$221M 8.4%
10,580,000
+160,000
+2% +$3.14M
CHTR icon
5
Charter Communications
CHTR
$17.3B
$204M 7.74%
605,000
-145,000
-19% -$48.4M
PODD icon
6
Insulet
PODD
$11.8B
$143M 5.45%
2,795,000
-55,000
-2% -$2.39M
TIF
7
DELISTED
Tiffany & Co.
TIF
$142M 5.4%
1,515,000
-145,000
-9% -$13.3M
GDX icon
8
VanEck Gold Miners ETF
GDX
$22.5B
$131M 4.96%
5,920,000
-1,725,000
-23% -$39.2M
AAP icon
9
Advance Auto Parts
AAP
$3.53B
$122M 4.63%
1,045,000
-45,000
-4% -$6.18M
ANDV
10
DELISTED
Andeavor
ANDV
$110M 4.19%
1,180,000
-635,000
-35% -$53.6M
ALNY icon
11
Alnylam Pharmaceuticals
ALNY
$38.3B
$90.5M 3.44%
1,135,000
-865,000
-43% -$55.3M
CAR icon
12
Avis
CAR
$5.47B
$84.5M 3.21%
+3,100,000
New +$79.9M
DXC icon
13
DXC Technology
DXC
$1.91B
$67.1M 2.55%
+1,011,500
New +$67.1M
P
14
DELISTED
Pandora Media Inc
P
$49.1M 1.87%
+5,505,000
New +$53M
MDCO
15
DELISTED
Medicines Co
MDCO
$20.7M 0.79%
545,000
-135,000
-20% -$6.01M
ATCO
16
DELISTED
Atlas Corp.
ATCO
$3.21M 0.12%
450,000
-110,000
-20% -$684K
DXCM icon
17
DexCom
DXCM
$29B
– –
-4,478,000
Closed -$94.9M
X
18
DELISTED
US Steel
X
– –
-3,115,000
Closed -$105M
XLF icon
19
State Street Financial Select Sector SPDR ETF
XLF
$56.5B
– –
-12,060,000
Closed -$286M

Similar funds

SPS
Susquehanna Portfolio Strategies Bala Cynwyd, Pennsylvania $6.73B AUM 45.57% 1-Year Est. Return
BHM
Briar Hall Management Nashville, Tennessee $6.72B AUM 4.95% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
CIMLRA
CBRE Investment Management Listed Real Assets Radnor, Pennsylvania $6.75B AUM 8.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $6.76B AUM 88.1% 1-Year Est. Return
MSE
MUFG Securities EMEA London, United Kingdom $6.7B AUM 32.3% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Slate Path Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Slate Path Capital held 19 positions worth $2.63B, up 29% from $2.04B the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Slate Path Capital deployed $495M of net new capital in Q2 2017, opening 5 new positions and adding to 2 existing holdings. Its largest new stake was Avis: 3,100,000 shares worth $84.5M.

By sector, the portfolio is most concentrated in Communication Services at 20% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Alnylam Pharmaceuticals, an estimated $55.3M trimmed.

  • Slate Path Capital's largest Q2 2017 buy was Avis: 3,100,000 shares worth $84.5M.
  • Slate Path Capital added most to Twitter, Inc. in Q2 2017, an estimated $34.1M increase.
  • Slate Path Capital's biggest Q2 2017 reduction was Alnylam Pharmaceuticals, cutting an estimated $55.3M.
  • Slate Path Capital fully exited State Street Financial Select Sector SPDR ETF in Q2 2017, selling an estimated $286M.
  • Slate Path Capital's ten largest holdings make up 88% of its $2.63B portfolio in Q2 2017.
  • Slate Path Capital opened 5 new positions and closed 3 in Q2 2017.
  • Slate Path Capital's portfolio value rose 29% quarter-over-quarter to $2.63B.

Based on Slate Path Capital's 13F filing for Q2 2017, filed 14 Aug 2017.